SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 132 filers reported holding SERES THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $126,000 | -72.9% | 17,719 | -68.3% | 0.01% | -79.3% |
| Q4 2021 | $465,000 | +278.0% | 55,836 | +214.7% | 0.03% | +190.0% |
| Q3 2021 | $123,000 | -56.5% | 17,742 | +29.1% | 0.01% | -61.5% |
| Q1 2021 | $283,000 | -21.2% | 13,739 | -6.1% | 0.03% | -31.6% |
| Q4 2020 | $359,000 | +12.9% | 14,639 | -78.1% | 0.04% | +72.7% |
| Q2 2020 | $318,000 | +119.3% | 66,779 | +367.0% | 0.02% | +37.5% |
| Q4 2017 | $145,000 | -43.6% | 14,300 | -44.8% | 0.02% | -61.0% |
| Q4 2016 | $257,000 | +99.2% | 25,924 | +147.5% | 0.04% | +41.4% |
| Q3 2016 | $129,000 | – | 10,474 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |